The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study)
NCT06628921
·
clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Migraine
Interventions
DRUG:
Eptinezumab 100 or 300 mg ev
Sponsor
University of Florence
Collaborators
[object Object]
[object Object]
[object Object]